Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.40 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.40 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.40 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.40 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.40 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.40 |
| ▸ | GALR3 | O60755 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29655367 | 0.82 | — | — | |
| SCHEMBL20446689 | 0.82 | — | — | |
| SCHEMBL24966524 | 0.82 | ALOX15 (0.47) | ALOX15ALDH1A1CHRNB2CHRNA4CHRM5 | |
| SCHEMBL27086 | 0.77 | — | — | |
| SCHEMBL7552905 | 0.77 | ALOX15 (0.70) | ALOX15ALDH1A1CHRNB2CHRNA4CHRM5 | |
| SCHEMBL901254 | 0.77 | ALOX15 (0.53) | ALOX15ALDH1A1CHRNB2CHRNA4CHRM5 | |
| SCHEMBL1571685 | 0.76 | ALOX15 (0.44) | ALOX15ALDH1A1CHRNB2CHRNA4CHRM5 | |
| SCHEMBL28846303 | 0.76 | ALOX15 (0.48) | ALOX15ALDH1A1CHRNB2CHRNA4CHRM5 | |
| SCHEMBL20581784 | 0.75 | — | — | |
| SCHEMBL25380570 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12635687-B2 | Aqueous hop extracts and their use as antimicrobial agents | Nature Recombined Sciences Inc. (CA) | 2026-05-26 | — | — | US | disclosed |
| WO-2026102046-A1 | GUM ACACIA-FREE AND WEIGHTING AGENT-FREE EMULSIONS | ABSTRAX TECH INC. (US) | 2026-05-15 | — | — | WO | disclosed |
| US-20260123645-A1 | GUM ACACIA-FREE AND WEIGHTING AGENT-FREE EMULSIONS | ABSTRAX TECH INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-12495817-B2 | Grape skin compositions and compounds, and methods of preparation and use therefor | PHANTASM LIMITED (NZ) | 2025-12-16 | — | — | US | disclosed |
| US-20250115834-A1 | COMPOSITIONS COMPRISING GRAPE SKIN EXTRACTS AND METHODS OF PREPARATION AND USE THEREOF | PHANTASM LIMITED (NZ) | 2025-04-10 | — | — | US | disclosed |
| US-20250043219-A1 | GRAPE SKIN COMPOSITIONS AND COMPOUNDS, AND METHODS OF PREPARATION AND USE THEREFOR | PHANTASM LIMITED (NZ) | 2025-02-06 | — | — | US | disclosed |
| US-20250017201-A1 | Aqueous Hop Extracts and Their Use as Antimicrobial Agents | Nature Recombined Sciences Inc. (CA) | 2025-01-16 | — | — | US | disclosed |
| EP-4466003-A1 | AQUEOUS HOP EXTRACTS AND THEIR USE AS ANTIMICROBIAL AGENTS | Nature Recombined Sciences Inc. (CA) | 2024-11-27 | — | — | EP | disclosed |
| US-12035710-B2 | Aqueous hop extracts and their use as antimicrobial agents | Nature Recombined Sciences Inc. (CA) | 2024-07-16 | — | — | US | disclosed |
| WO-2023137555-A1 | AQUEOUS HOP EXTRACTS AND THEIR USE AS ANTIMICROBIAL AGENTS | Nature Recombined Sciences Inc. (CA) | 2023-07-27 | — | — | WO | disclosed |
| US-20230232822-A1 | Aqueous Hop Extracts and Their Use as Antimicrobial Agents | Nature Recombined Sciences Inc. (CA) | 2023-07-27 | — | — | US | disclosed |
| WO-2023106937-A1 | GRAPE SKIN COMPOSITIONS AND COMPOUNDS, AND METHODS OF PREPARATION AND USE THEREFOR | PHANTASM LIMITED (NZ) | 2023-06-15 | — | — | WO | disclosed |
| WO-2023106936-A1 | COMPOSITIONS COMPRISING GRAPE SKIN EXTRACTS AND METHODS OF PREPARATION AND USE THEREOF | PHANTASM LIMITED (NZ) | 2023-06-15 | — | — | WO | disclosed |
| EP-4165159-A1 | GRAPE SKIN COMPOSITIONS AND COMPOUNDS, AND METHODS OF PREPARATION AND USE THEREFOR | Phantasm Limited (NZ) | 2023-04-19 | — | — | EP | disclosed |
| US-20230022145-A1 | GRAPE SKIN COMPOSITIONS AND COMPOUNDS, AND METHODS OF PREPARATION AND USE THEREFOR | PHANTASM LIMITED (NZ) | 2023-01-26 | — | — | US | disclosed |
| WO-2020025545-A1 | METHOD AND DEVICE FOR TREATING HOPS DURING BEER-MAKING | KRONES AG (DE) | 2020-02-06 | — | — | WO | disclosed |
| JP-2008214261-A | AROMATIC COMPOUND, AROMATIC COMPOSITION AND AROMATIC HOP EXTRACT | SAPPORO BREWERIES LTD | 2008-09-18 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12635687-B2 | Aqueous hop extracts and their use as antimicrobial agents | HGF, STMN1, SGK1 | ALOX15 4447/4885ALDH1A1 4672/4885CHRNB2 2680/4885 |
| US-20260123645-A1 | GUM ACACIA-FREE AND WEIGHTING AGENT-FREE EMULSIONS | HIRA, NAPEPLD, S100P | ALOX15 478/4885ALDH1A1 2238/4885CHRNB2 1805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.